ICU Clinical Trials in Changchun, Jilin
7 recruitingChangchun, Jilin, China
Showing 1–7 of 7 trials
Recruiting
Phase 3
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma
Marginal Zone LymphomaRelapsed/Refractory Follicular Lymphoma
BeOne Medicines780 enrolled277 locationsNCT05100862
Recruiting
Not Applicable
Anti-CoagulaTion on Left Ventricular Thrombus After ST Segment Elevation Myocardial Infarction
left ventricular thrombusST-segment elevation myocardial infarction (STEMI)
Jilin University320 enrolled1 locationNCT05892042
Recruiting
Phase 3
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
Follicular Lymphoma
Celgene400 enrolled160 locationsNCT06911502
Recruiting
Phase 1Phase 2
Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader
Non-Hodgkin LymphomaMantle Cell LymphomaFollicular Lymphoma+6 more
BeiGene146 enrolled29 locationsNCT05294731
Recruiting
Not Applicable
The PRE-VAIL Study
ARDS (Moderate or Severe)Prone PositionEnteral Nutrition Feeding+1 more
The First Hospital of Jilin University259 enrolled1 locationNCT07176624
Recruiting
Not Applicable
mNEED: a Multicentre, Cluster-randomized, Controlled Trial
ICUfeeding
The First Hospital of Jilin University2,250 enrolled2 locationsNCT06827275
Recruiting
Not Applicable
R-CDOP Regimen in the Treatment of Newly Diagnosed Non-Hodgkin's Lymphoma With High Tumor Burden
Diffuse Large B Cell LymphomaFollicular Lymphoma Grade 3B
oubai, MD/PhD64 enrolled1 locationNCT05040555